<p>隨着亞洲市場在主要指數表現不一的環境中航行，投資者越來越關注潛在增長的細分機會。便士股票通常與較小或較新的公司相關，由於其在穩健財務支持下的顯著回報潛力，繼續吸引關注。儘管這個術語已經過時，這些股票為發現被大型市場參與者忽視的優質公司的隱藏價值提供了獨特機會。</p>
<h3>亞洲十大便士股票</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>股價</strong></td>
<td><strong>市值</strong></td>
<td><strong>回報與風險</strong></td>
</tr>
<tr>
<td>利華控股集團 (SEHK:1346)</td>
<td>HK$1.45</td>
<td>HK$896.85M</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>亞洲醫學與農業實驗室及研究中心 (SET:AMARC)</td>
<td>THB2.50</td>
<td>THB1.05B</td>
<td>✅ 3 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>TK 集團 (控股) (SEHK:2283)</td>
<td>HK$2.55</td>
<td>HK$2.12B</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>大西洋航運控股 (新加坡) (Catalist:5UL)</td>
<td>SGD0.108</td>
<td>SGD56.54M</td>
<td>✅ 2 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>揚子江造船 (控股) (SGX:BS6)</td>
<td>SGD3.56</td>
<td>SGD14.01B</td>
<td>✅ 5 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>安東油田服務集團 (SEHK:3337)</td>
<td>HK$0.79</td>
<td>HK$2.1B</td>
<td>✅ 3 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>娜迦控股 (SEHK:3918)</td>
<td>HK$4.81</td>
<td>HK$21.27B</td>
<td>✅ 5 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>畜牧改良 (NZSE:LIC)</td>
<td>NZ$1.00</td>
<td>NZ$137.01M</td>
<td>✅ 2 ⚠️ 5 查看分析 </td>
</tr>
<tr>
<td>波司登國際控股 (SEHK:3998)</td>
<td>HK$4.40</td>
<td>HK$51.08B</td>
<td>✅ 4 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>斯科特科技 (NZSE:SCT)</td>
<td>NZ$2.88</td>
<td>NZ$237.99M</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
</tbody>
</table>
<p>點擊這裏查看我們亞洲便士股票篩選器的完整列表，共 954 只股票。</p>
<p>讓我們從我們的專業篩選器中發現一些寶藏。</p>
<h2>鎳亞洲 (PSE:NIKL)</h2>
<p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> 鎳亞洲公司在菲律賓運營，專注於鎳沙岩、紅土礦、石灰石和採石材料的開採與勘探，市值為₱61.58 億。</p>
<p><strong>運營：</strong> 公司的收入主要來自其採礦業務，來自 TMC 的採礦收入為₱10.81 億，來自 RTN 的採礦收入為₱7.87 億，來自 HMC 的採礦收入為₱3.11 億，以及來自 CMC 的採礦收入為₱3.49 億；額外收入來自於電力生產，通過 EPI 的電力收入為₱1.03 億和 NAC 的電力收入為₱212.40 萬，以及 RTN/TMC/CDTN 提供的服務收入為₱1.03 億。</p>
<p><strong>市值：</strong> ₱61.58B</p>
<p>鎳亞洲公司市值為₱61.58 億，最近顯示出強勁的財務表現，與去年相比，報告了顯著的收入和淨收入增長。公司宣佈將在 2025 年 12 月支付特別股息，表明其強大的現金流管理。儘管其債務在五年內有所增加，但仍然由運營現金流良好覆蓋，並且有大量短期資產超過負債。然而，其盈利增長未能與更廣泛的行業趨勢相匹配，預測顯示未來盈利可能下降。管理層正在進行變更，以潛在提升戰略方向和治理穩定性。</p>
<ul>
<li>在我們的財務健康報告中更深入地瞭解鎳亞洲的潛力。</li>
<li>查看我們的增長表現報告，以獲取鎳亞洲未來的見解。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/71521775-7c93-4df8-9cf4-9452912187e3/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/71521775-7c93-4df8-9cf4-9452912187e3/chart/debt-equity-history-analysis"/></p>
<p>PSE:NIKL 債務與股本歷史及分析截至 2026 年 1 月</p>
<h2>金海醫療科技 (SEHK:2225)</h2>
<p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> 金海醫療科技有限公司是一家投資控股公司，提供微創手術解決方案、醫療產品及相關服務，業務覆蓋中華人民共和國和新加坡，市值為 HK$72.5 億。</p>
<p><strong>運營：</strong> 公司的收入主要來自兩個主要地區：新加坡貢獻 SGD 14.82 百萬，中華人民共和國貢獻 SGD 19.83 百萬。</p>
<p><strong>市值：</strong> HK$7.25B</p>
<p>儘管金海醫療科技市值為 HK$72.5 億，但面臨財務挑戰，因其仍處於虧損狀態，五年內虧損年增幅達到 83.8%。公司擁有 SGD 23.7 百萬的短期資產，超過其短期和長期負債，顯示出良好的流動性。儘管最近籌集資金以延長現金流動期超過初步三個月的預測，但淨債務與股本比率為 16.5%，處於令人滿意的水平。管理層和董事會成員經驗豐富，平均任期分別為 4.3 年和 6.5 年，為在持續的財務困難中提供穩定性。</p>
<ul>
<li>通過我們的綜合資產負債表健康報告深入瞭解金海醫療科技的複雜性。</li>
<li>通過檢查我們的業績歷史報告瞭解金海醫療科技的業績記錄。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/ccd9a18e-dbb5-46fb-99c8-c261510fae35/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/ccd9a18e-dbb5-46fb-99c8-c261510fae35/chart/financial-position-analysis"/></p>
<p>SEHK:2225 財務狀況分析截至 2026 年 1 月</p>
<h2>揚子江金融控股 (SGX:YF8)</h2>
<p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★★</p>
<p><strong>概述：</strong> 揚子江金融控股有限公司是一家投資控股公司，涉及中國和新加坡的投資相關活動，市值為 SGD1.41 億。</p>
<p><strong>運營：</strong> 該公司從其投資業務部門產生 SGD288.47 百萬的收入。</p>
<p><strong>市值：</strong> SGD1.41B</p>
<p>揚子江金融控股有限公司市值為 14.1 億新加坡元，財務狀況良好，其 22 億新加坡元的短期資產顯著超過短期和長期負債，並且公司無債務。儘管過去一年盈利增長了 128.4%，但未來三年預計年均盈利將下降 5.7%。公司的股票交易價格顯著低於估計的公允價值，但近期股價波動性較大。最近的高管變動包括在戰略分拆決策後對關鍵職位的新任命，暗示公司方向可能發生變化。</p>
<ul>
<li>點擊這裏訪問我們完整的財務健康分析報告，以瞭解揚子江金融控股的動態。</li>
<li>在這裏瞭解揚子江金融控股的未來增長軌跡。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/7358319a-6c0f-4248-9a3c-8518deecdc12/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/7358319a-6c0f-4248-9a3c-8518deecdc12/chart/debt-equity-history-analysis"/></p>
<p>截至 2026 年 1 月 SGX:YF8 的債務與股本歷史及分析</p>
<h2>接下來該如何？</h2>
<ul>
<li>點擊這裏解鎖我們 954 只亞洲便士股票的綜合列表。</li>
<li>準備好採取不同的方法了嗎？特朗普承諾將 “釋放” 美國的石油和天然氣，這 22 只美國股票的發展有望受益。</li>
</ul>
<p><em>本文由 Simply Wall St 撰寫，內容具有一般性。<strong>我們基於歷史數據和分析師預測提供評論，僅使用無偏見的方法，我們的文章不構成財務建議。</strong> 這並不構成買入或賣出任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。</em></p>

利華控股集團

<p>隨着亞洲市場表現不一，投資者正將目光投向低價股以尋求潛在增長。這些與小型公司相關的股票提供了顯著回報的機會。值得一提的公司包括利華控股集團、亞洲醫療與農業實驗室以及儘管債務增加但財務表現強勁的鎳亞洲公司。金海醫療科技面臨盈利挑戰，而揚子江金融控股則展現出強健的財務狀況，但預計未來收益將下降。總體而言，亞洲的低價股市場為尋求隱藏價值的投資者提供了風險與回報並存的機會</p>

<p>As the Asian markets navigate a landscape marked by mixed performances in key indices, investors are increasingly looking toward niche opportunities for potential growth. Penny stocks, often associated with smaller or newer companies, continue to capture attention due to their potential for significant returns when backed by solid financials. Despite being an outdated term, these stocks provide a unique opportunity for discovering hidden value in quality companies that might be overlooked by larger market players.</p>
<div class="lb-trans"><p>隨着亞洲市場在主要指數表現不一的環境中航行，投資者越來越關注潛在增長的細分機會。便士股票通常與較小或較新的公司相關，由於其在穩健財務支持下的顯著回報潛力，繼續吸引關注。儘管這個術語已經過時，這些股票為發現被大型市場參與者忽視的優質公司的隱藏價值提供了獨特機會。</p>
</div><h3>Top 10 Penny Stocks In Asia</h3>
<div class="lb-trans"><h3>亞洲十大便士股票</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Share Price</strong></td>
<td><strong>Market Cap</strong></td>
<td><strong>Rewards &amp; Risks</strong></td>
</tr>
<tr>
<td>Lever Style (SEHK:1346)</td>
<td>HK$1.45</td>
<td>HK$896.85M</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Asia Medical and Agricultural Laboratory and Research Center (SET:AMARC)</td>
<td>THB2.50</td>
<td>THB1.05B</td>
<td>✅ 3 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>TK Group (Holdings) (SEHK:2283)</td>
<td>HK$2.55</td>
<td>HK$2.12B</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Atlantic Navigation Holdings (Singapore) (Catalist:5UL)</td>
<td>SGD0.108</td>
<td>SGD56.54M</td>
<td>✅ 2 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Yangzijiang Shipbuilding (Holdings) (SGX:BS6)</td>
<td>SGD3.56</td>
<td>SGD14.01B</td>
<td>✅ 5 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Anton Oilfield Services Group (SEHK:3337)</td>
<td>HK$0.79</td>
<td>HK$2.1B</td>
<td>✅ 3 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>NagaCorp (SEHK:3918)</td>
<td>HK$4.81</td>
<td>HK$21.27B</td>
<td>✅ 5 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Livestock Improvement (NZSE:LIC)</td>
<td>NZ$1.00</td>
<td>NZ$137.01M</td>
<td>✅ 2 ⚠️ 5 View Analysis &gt;</td>
</tr>
<tr>
<td>Bosideng International Holdings (SEHK:3998)</td>
<td>HK$4.40</td>
<td>HK$51.08B</td>
<td>✅ 4 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>Scott Technology (NZSE:SCT)</td>
<td>NZ$2.88</td>
<td>NZ$237.99M</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>股價</strong></td>
<td><strong>市值</strong></td>
<td><strong>回報與風險</strong></td>
</tr>
<tr>
<td>利華控股集團 (SEHK:1346)</td>
<td>HK$1.45</td>
<td>HK$896.85M</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>亞洲醫學與農業實驗室及研究中心 (SET:AMARC)</td>
<td>THB2.50</td>
<td>THB1.05B</td>
<td>✅ 3 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>TK 集團 (控股) (SEHK:2283)</td>
<td>HK$2.55</td>
<td>HK$2.12B</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>大西洋航運控股 (新加坡) (Catalist:5UL)</td>
<td>SGD0.108</td>
<td>SGD56.54M</td>
<td>✅ 2 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>揚子江造船 (控股) (SGX:BS6)</td>
<td>SGD3.56</td>
<td>SGD14.01B</td>
<td>✅ 5 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>安東油田服務集團 (SEHK:3337)</td>
<td>HK$0.79</td>
<td>HK$2.1B</td>
<td>✅ 3 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>娜迦控股 (SEHK:3918)</td>
<td>HK$4.81</td>
<td>HK$21.27B</td>
<td>✅ 5 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>畜牧改良 (NZSE:LIC)</td>
<td>NZ$1.00</td>
<td>NZ$137.01M</td>
<td>✅ 2 ⚠️ 5 查看分析 </td>
</tr>
<tr>
<td>波司登國際控股 (SEHK:3998)</td>
<td>HK$4.40</td>
<td>HK$51.08B</td>
<td>✅ 4 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>斯科特科技 (NZSE:SCT)</td>
<td>NZ$2.88</td>
<td>NZ$237.99M</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 954 stocks from our Asian Penny Stocks screener.</p>
<div class="lb-trans"><p>點擊這裏查看我們亞洲便士股票篩選器的完整列表，共 954 只股票。</p>
</div><p>Let's uncover some gems from our specialized screener.</p>
<div class="lb-trans"><p>讓我們從我們的專業篩選器中發現一些寶藏。</p>
</div><h2>Nickel Asia (PSE:NIKL)</h2>
<div class="lb-trans"><h2>鎳亞洲 (PSE:NIKL)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Nickel Asia Corporation operates in the Philippines, focusing on the mining and exploration of nickel saprolite, limonite ore, limestone, and quarry materials with a market capitalization of ₱61.58 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 鎳亞洲公司在菲律賓運營，專注於鎳沙岩、紅土礦、石灰石和採石材料的開採與勘探，市值為₱61.58 億。</p>
</div><p><strong>Operations:</strong> The company's revenue is primarily derived from its mining operations, with significant contributions from Mining - TMC (₱10.81 billion), Mining - RTN (₱7.87 billion), Mining - HMC (₱3.11 billion), and Mining - CMC (₱3.49 billion); additional income comes from power generation through Power - EPI (₱1.03 billion) and Power - NAC (₱212.40 million), as well as services provided by RTN/TMC/CDTN amounting to ₱1.03 billion.</p>
<div class="lb-trans"><p><strong>運營：</strong> 公司的收入主要來自其採礦業務，來自 TMC 的採礦收入為₱10.81 億，來自 RTN 的採礦收入為₱7.87 億，來自 HMC 的採礦收入為₱3.11 億，以及來自 CMC 的採礦收入為₱3.49 億；額外收入來自於電力生產，通過 EPI 的電力收入為₱1.03 億和 NAC 的電力收入為₱212.40 萬，以及 RTN/TMC/CDTN 提供的服務收入為₱1.03 億。</p>
</div><p><strong>Market Cap:</strong> ₱61.58B</p>
<div class="lb-trans"><p><strong>市值：</strong> ₱61.58B</p>
</div><p>Nickel Asia Corporation, with a market cap of ₱61.58 billion, has shown robust financial performance recently, reporting significant revenue and net income growth compared to the previous year. The company declared special dividends payable in December 2025, indicating strong cash flow management. Despite its debt increasing over five years, it remains well-covered by operating cash flow and is supported by substantial short-term assets exceeding liabilities. However, its earnings growth doesn't match the broader industry trends and forecasts suggest a potential decline in future earnings. Management changes are underway to potentially enhance strategic direction and governance stability.</p>
<div class="lb-trans"><p>鎳亞洲公司市值為₱61.58 億，最近顯示出強勁的財務表現，與去年相比，報告了顯著的收入和淨收入增長。公司宣佈將在 2025 年 12 月支付特別股息，表明其強大的現金流管理。儘管其債務在五年內有所增加，但仍然由運營現金流良好覆蓋，並且有大量短期資產超過負債。然而，其盈利增長未能與更廣泛的行業趨勢相匹配，預測顯示未來盈利可能下降。管理層正在進行變更，以潛在提升戰略方向和治理穩定性。</p>
</div><ul>
<li>Take a closer look at Nickel Asia's potential here in our financial health report.</li>
<li>Review our growth performance report to gain insights into Nickel Asia's future.</li>
</ul>
<div class="lb-trans"><ul>
<li>在我們的財務健康報告中更深入地瞭解鎳亞洲的潛力。</li>
<li>查看我們的增長表現報告，以獲取鎳亞洲未來的見解。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/71521775-7c93-4df8-9cf4-9452912187e3/chart/debt-equity-history-analysis" alt="" original-src="https://images.simplywall.st/company/71521775-7c93-4df8-9cf4-9452912187e3/chart/debt-equity-history-analysis"/></p>
<p>PSE:NIKL Debt to Equity History and Analysis as at Jan 2026</p>
<div class="lb-trans"><p>PSE:NIKL 債務與股本歷史及分析截至 2026 年 1 月</p>
</div><h2>Jinhai Medical Technology (SEHK:2225)</h2>
<div class="lb-trans"><h2>金海醫療科技 (SEHK:2225)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Jinhai Medical Technology Limited is an investment holding company that offers minimally invasive surgery solutions, medical products, and related services in the People's Republic of China and Singapore, with a market cap of HK$7.25 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 金海醫療科技有限公司是一家投資控股公司，提供微創手術解決方案、醫療產品及相關服務，業務覆蓋中華人民共和國和新加坡，市值為 HK$72.5 億。</p>
</div><p><strong>Operations:</strong> The company's revenue is derived from two primary regions: Singapore, contributing SGD 14.82 million, and the People's Republic of China, accounting for SGD 19.83 million.</p>
<div class="lb-trans"><p><strong>運營：</strong> 公司的收入主要來自兩個主要地區：新加坡貢獻 SGD 14.82 百萬，中華人民共和國貢獻 SGD 19.83 百萬。</p>
</div><p><strong>Market Cap:</strong> HK$7.25B</p>
<div class="lb-trans"><p><strong>市值：</strong> HK$7.25B</p>
</div><p>Jinhai Medical Technology faces financial challenges despite its HK$7.25 billion market cap, as it remains unprofitable with losses increasing by 83.8% annually over five years. The company has short-term assets of SGD 23.7 million exceeding both its short and long-term liabilities, indicating a solid liquidity position. Although it recently raised capital to extend its cash runway beyond the initial three months forecast, the net debt to equity ratio is satisfactory at 16.5%. Management and board members bring experience with average tenures of 4.3 and 6.5 years respectively, providing stability amid ongoing financial hurdles.</p>
<div class="lb-trans"><p>儘管金海醫療科技市值為 HK$72.5 億，但面臨財務挑戰，因其仍處於虧損狀態，五年內虧損年增幅達到 83.8%。公司擁有 SGD 23.7 百萬的短期資產，超過其短期和長期負債，顯示出良好的流動性。儘管最近籌集資金以延長現金流動期超過初步三個月的預測，但淨債務與股本比率為 16.5%，處於令人滿意的水平。管理層和董事會成員經驗豐富，平均任期分別為 4.3 年和 6.5 年，為在持續的財務困難中提供穩定性。</p>
</div><ul>
<li>Navigate through the intricacies of Jinhai Medical Technology with our comprehensive balance sheet health report here.</li>
<li>Understand Jinhai Medical Technology's track record by examining our performance history report.</li>
</ul>
<div class="lb-trans"><ul>
<li>通過我們的綜合資產負債表健康報告深入瞭解金海醫療科技的複雜性。</li>
<li>通過檢查我們的業績歷史報告瞭解金海醫療科技的業績記錄。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/ccd9a18e-dbb5-46fb-99c8-c261510fae35/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/ccd9a18e-dbb5-46fb-99c8-c261510fae35/chart/financial-position-analysis"/></p>
<p>SEHK:2225 Financial Position Analysis as at Jan 2026</p>
<div class="lb-trans"><p>SEHK:2225 財務狀況分析截至 2026 年 1 月</p>
</div><h2>Yangzijiang Financial Holding (SGX:YF8)</h2>
<div class="lb-trans"><h2>揚子江金融控股 (SGX:YF8)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Yangzijiang Financial Holding Ltd. is an investment holding company involved in investment-related activities in China and Singapore, with a market cap of SGD1.41 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 揚子江金融控股有限公司是一家投資控股公司，涉及中國和新加坡的投資相關活動，市值為 SGD1.41 億。</p>
</div><p><strong>Operations:</strong> The company generates revenue of SGD288.47 million from its investment business segment.</p>
<div class="lb-trans"><p><strong>運營：</strong> 該公司從其投資業務部門產生 SGD288.47 百萬的收入。</p>
</div><p><strong>Market Cap:</strong> SGD1.41B</p>
<div class="lb-trans"><p><strong>市值：</strong> SGD1.41B</p>
</div><p>Yangzijiang Financial Holding Ltd., with a market cap of SGD1.41 billion, shows strong financial health as its short-term assets of SGD2.2 billion surpass both short and long-term liabilities significantly, and it operates debt-free. Despite earnings growth of 128.4% over the past year, future earnings are expected to decline by an average of 5.7% annually over the next three years. The company's stock trades at a significant discount to estimated fair value, but high volatility persists in its share price recently. Recent executive changes include new appointments in key positions following a strategic spin-off decision, suggesting potential shifts in company direction.</p>
<div class="lb-trans"><p>揚子江金融控股有限公司市值為 14.1 億新加坡元，財務狀況良好，其 22 億新加坡元的短期資產顯著超過短期和長期負債，並且公司無債務。儘管過去一年盈利增長了 128.4%，但未來三年預計年均盈利將下降 5.7%。公司的股票交易價格顯著低於估計的公允價值，但近期股價波動性較大。最近的高管變動包括在戰略分拆決策後對關鍵職位的新任命，暗示公司方向可能發生變化。</p>
</div><ul>
<li>Click here and access our complete financial health analysis report to understand the dynamics of Yangzijiang Financial Holding.</li>
<li>Learn about Yangzijiang Financial Holding's future growth trajectory here.</li>
</ul>
<div class="lb-trans"><ul>
<li>點擊這裏訪問我們完整的財務健康分析報告，以瞭解揚子江金融控股的動態。</li>
<li>在這裏瞭解揚子江金融控股的未來增長軌跡。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/7358319a-6c0f-4248-9a3c-8518deecdc12/chart/debt-equity-history-analysis" alt="" original-src="https://images.simplywall.st/company/7358319a-6c0f-4248-9a3c-8518deecdc12/chart/debt-equity-history-analysis"/></p>
<p>SGX:YF8 Debt to Equity History and Analysis as at Jan 2026</p>
<div class="lb-trans"><p>截至 2026 年 1 月 SGX:YF8 的債務與股本歷史及分析</p>
</div><h2>Where To Now?</h2>
<div class="lb-trans"><h2>接下來該如何？</h2>
</div><ul>
<li>Unlock our comprehensive list of 954 Asian Penny Stocks by clicking here.</li>
<li>Ready For A Different Approach? Trump has pledged to &#34;unleash&#34; American oil and gas and these 22 US stocks have developments that are poised to benefit.</li>
</ul>
<div class="lb-trans"><ul>
<li>點擊這裏解鎖我們 954 只亞洲便士股票的綜合列表。</li>
<li>準備好採取不同的方法了嗎？特朗普承諾將 “釋放” 美國的石油和天然氣，這 22 只美國股票的發展有望受益。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>本文由 Simply Wall St 撰寫，內容具有一般性。<strong>我們基於歷史數據和分析師預測提供評論，僅使用無偏見的方法，我們的文章不構成財務建議。</strong> 這並不構成買入或賣出任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。</em></p>
</div>

亞洲市場亮點：2026 年 1 月值得關注的低價股